Volume 24, Issue 22 (19 May 2005)



Uncovering MYC's full oncogenic potential in the hematopoietic system

Siegfried Janz

Oncogene 24: 3541-3543; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208473


Original Papers

T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC

Darrin P Smith, Mary L Bath, Alan W Harris and Suzanne Cory

Oncogene 24: 3544-3553; advance online publication, January 31, 2005; doi:10.1038/sj.onc.1208399

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer

Laundette P Jones, Minglin Li, Ewa D Halama, Yongxian Ma, Ronald Lubet, Clinton J Grubbs, Chu-Xia Deng, Eliot M Rosen and Priscilla A Furth

Oncogene 24: 3554-3562; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208426

p53 must be competent for transcriptional regulation to suppress tumor formation

Monica Nistér, Mengjia Tang, Xiao-Qun Zhang, Chaoying Yin, Michelle Beeche, Xinrong Hu, Gunilla Enblad, Terry van Dyke and Geoffrey M Wahl

Oncogene 24: 3563-3573; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208354

Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells

Hui Qin Wang, Deborah A Altomare, Kristine L Skele, Poulikos I Poulikakos, Francis P Kuhajda, Antonio Di Cristofano and Joseph R Testa

Oncogene 24: 3574-3582; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208463

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

Bobby Bhatia, Shaohua Tang, Peiying Yang, Andreas Doll, Gerhard Aumüeller, Robert A Newman and Dean G Tang

Oncogene 24: 3583-3595; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208406

Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth

Lincoln A Edwards, B Thiessen, Wieslawa H Dragowska, Tim Daynard, Marcel B Bally and Shoukat Dedhar

Oncogene 24: 3596-3605; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208427

YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene

Ulrike Stein, Stephan Bergmann, George L Scheffer, Rik J Scheper, Hans-Dieter Royer, Peter M Schlag and Wolfgang Walther

Oncogene 24: 3606-3618; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208386

Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression

Hong Ma, Cu Nguyen, Kyung-Soon Lee and Michael Kahn

Oncogene 24: 3619-3631; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208433

Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor

Balveen Kaur, Daniel J Brat, Narra S Devi and Erwin G Van Meir

Oncogene 24: 3632-3642; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208317

c-FMS chromatin structure and expression in normal and leukaemic myelopoiesis

George Alexander Follows, Hiromi Tagoh, Stephen John Richards, Svitlana Melnik, Helen Dickinson, Erica de Wynter, Pascal Lefevre, Gareth John Morgan and Constanze Bonifer

Oncogene 24: 3643-3651; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208655

Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer

Sean T Martin, Hiroyuki Matsubayashi, Carmelle D Rogers, Juliet Philips, Fergus J Couch, Kieran Brune, Charles J Yeo, Scott E Kern, Ralph H Hruban and Michael Goggins

Oncogene 24: 3652-3656; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208411

Modulation of CDK2-AP1 (p12DOC-1) expression in human colorectal cancer

Ziquan Yuan, Anu G Gaba, Tara Sotsky Kent, Anna Bennett, Agnes Miller and Thomas K Weber

Oncogene 24: 3657-3668; advance online publication, April 4, 2005; doi:10.1038/sj.onc.1208378

Induction of apoptosis by the synthetic retinoid MX3350-1 through extrinsic and intrinsic pathways in head and neck squamous carcinoma cells

Kyung-Hee Chun, Magnus Pfahl and Reuben Lotan

Oncogene 24: 3669-3677; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208339


Short Reports

Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia

Nirosha Suraweera, Emmy Meijne, John Moody, Luis G Carvajal-Carmona, Kazuko Yoshida, Patrick Pollard, Jude Fitzgibbon, Andrew Riches, Theo van Laar, Rene Huiskamp, Andrew Rowan, Ian P M Tomlinson and Andrew Silver

Oncogene 24: 3678-3683; advance online publication, March 7, 2005; doi:10.1038/sj.onc.1208422

Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line

Eriko Fujimoto, Hiromi Sato, Sumiko Shirai, Yoji Nagashima, Keiko Fukumoto, Hiromi Hagiwara, Etsuko Negishi, Koichi Ueno, Yasufumi Omori, Hiroshi Yamasaki, Kiyokazu Hagiwara and Tomohiro Yano

Oncogene 24: 3684-3690; advance online publication, March 14, 2005; doi:10.1038/sj.onc.1208430

Genetic interactions between RAD51 and its paralogues for centrosome fragmentation and ploidy control, independently of the sensitivity to genotoxic stresses

Fayza Daboussi, John Thacker and Bernard S Lopez

Oncogene 24: 3691-3696; advance online publication, March 21, 2005; doi:10.1038/sj.onc.1208438

Extra navigation